Brief: Waverley Pharma Announces Grant Of Market Authorization For Pemetrexed And Bortezomib In Multiple European Countries
30/07/2020 14:41
July 30 (Reuters) - Waverley Pharma Inc WAVE.V :
* WAVERLEY PHARMA ANNOUNCES GRANT OF MARKET AUTHORIZATION
FOR
PEMETREXED AND BORTEZOMIB IN MULTIPLE EUROPEAN COUNTRIES
Source text for Eikon: ID:nCNWGQ9fTa
Further company coverage: WAVE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Waverley Pharma
See all newsBrief: Waverley Pharma Announces Chief Financial Officer Change
Brief: Waverley Pharma Acquires Us Based Pharmacy
Brief: Waverley Pharma Business Update
Brief: Waverley Pharma Provides Update On Its Parp-1 Inhibitor Program
Brief: Waverley Pharma - Co's Unit Awarded Exclusive Distribution Rights For Two Strengths Of Pemetrexed By NHS England